Latest News
Beximco Pharma’s Q1’ 13 Results Announced
BEXIMCO PHARMACEUTICALS LTD.
15 May, 2013
Beximco Pharma’s Q1’ 13 Results Announced
Beximco Pharmaceuticals Limited ("BPL" or "the Company"; AIM Symbol: BXP), today announces its unaudited financial results for the First quarter ended 31 March 2013 in compliance with the requirements from the Bangladesh SEC
Price Sensitive Information
This is for information of all concerned that the Board of Directors of the Company in their meeting held on 30 April, 2013 at 3.30 p.m. has approved the audited Financial Statements for the year ended 31 December, 2012. 15% stock dividend has been recommended and the AGM and record date has been fixed.
Press Releases 1 May 2013
Beximco Pharma Enters EU Market
BEXIMCO PHARMACEUTICALS LTD.
February 11, 2013
News Release
Beximco Pharma Enters EU Market
Beximco Pharmaceuticals Limited (“BPL” or “the Company”; AIM Symbol: BXP), the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, today announces that it has commenced export of Company products to Europe.
Initially shipments of two ophthalmic products, Latanoprost and a combination of Latanoprost and Timolol, will be exported to Germany and Austria with other EU countries to follow. Latanoprost and Timolol are used to reduce the pressure inside the eye for people with open-angle glaucoma or intraocular hypertension (increased pressure in the eye). The Company expects to launch additional new products in the EU later this year.
BEXIMCO PHARMACEUTICALS LTD.
31 October, 2012
Beximco Pharma’s Q3’ 12 Results Announced
Beximco Pharmaceuticals Limited ("BPL" or "the Company"; AIM Symbol: BXP), today announces its unaudited financial results for the third quarter and nine months ended 30 September 2012 in compliance with the requirements from the Bangladesh SEC
The accounts can be viewed at the company’s website
Notice of the Thirty-Sixth Annual General Meeting
Notice is hereby given that the THIRTY-SIXTH ANNUAL GENERAL MEETING of the Shareholders of Beximco Pharmaceuticals Limited will be held on Saturday, the 30th June, 2012 at 10.30 a.m. at Beximco Industrial Park, Sarabo, Kashimpur, Gazipur to transact the following business:
Press Releases 17 May 2012
Beximco Pharma Announces First Quarter Financial Statements, 2012
We are pleased to present the un-audited Financial Statements of Beximco Pharmaceuticals Ltd.for the third quarter ended March 30, 2012 as per Securities and Exchange Commission Notification No. SEC/CMRRCD/2008-183/Admin/03-34 dated September 27, 2009.
Price Sensitive Information 28 April, 2012
This is for information of all concerned that the Board of Directors of the Company in its meeting held on 28 April, 2012 at 3.30 p.m. has approved the audited Financial Statements for the year ended 31 December, 2011 and took the following decisions:
Beximco Pharma Introduces Tablet PC for Pharma marketing
BEXIMCO PHARMACEUTICALS LTD.
News Release
28 February, 2012
Beximco Pharmaceuticals Ltd. is always committed to serving the medical community with innovative and academic services. The Company’s latest move was to equip the vision team task force with tablets - mobiles computers with touchscreen and pen-anabled interface – for the purpose of “pharmaceutical detailing”. This maneuver will not only keep the busy physicians uptodate about recent advances in medical science with prompt and quality services, this will help promote environmental awareness by reducing use of papers where practicable. The medical representatives can instantly pull up whatever references a doctor may wish to study. From the comfort of their own desks, doctors will now have the option of taking a tour in Beximco Pharma’s Ophthalmic manufacturing facility; which incidentally is the country’s one and only facility to have been awarded with Australian and European GMP (Good Manufacturing Practices) accreditations. This contemporary tactic is a first for Bangladesh.
Read more: Beximco Pharma Introduces Tablet PC for Pharma marketing
Beximco Pharma Announces Third Quarter Financial Statements, 2011
We are pleased to present the un-audited Financial Statements of Beximco Pharmaceuticals Ltd.for the third quarter ended September 30, 2011 as per Securities and Exchange CommissionNotification No. SEC/CMRRCD/2008-183/Admin/03-34 dated September 27, 2009.
Beximco Phrama joins Mobile Alliance for Maternal Action (MAMA)
BEXIMCO PHARMACEUTICALS LTD.
3rd August, 2011
Beximco Phrama joins Mobile Alliance for Maternal Action (MAMA)
Beximco Pharmaceuticals Limited (“Beximco Pharma” or the “Company”) has joined Mobile Alliance for Maternal Action (MAMA) in Bangladesh, an innovative coalition to use mobile phones for delivering life-saving health information to expectant and new mothers in Bangladesh. The Company has signed an agreement with D.Net, a social enterprise and the Coalition Coordinator of the MAMA initiative, at a simple ceremony held at Beximco Pharma’s Corporate Office on July 19, 2011. Ministry of Health and Family Welfare (MoHFW) and Access to Information (A2I) Programme at Prime Minister's Office are official partners of the initiative.
Read more: Beximco Phrama joins Mobile Alliance for Maternal Action (MAMA)
Page 1 of 5
Welcome to the registered Health Professionals, to this exclusive Doctors only area. This provides you access to latest medical updates, events, guidelines and information relevant to your practice. If you are not a registered doctor please do not enter this area. 
Life's all about staying healthy and enjoying the good things in life! However, illness is inevitable at all stages of life. In this area learn about the common health problems and how to deal with your and your family's illness.